Drugs / Technosphere Insulin SAR439065
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02485327 | Jul → Nov 2015 | type 1 diabetes mellitus | Mannkind Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Technosphere Insulin SAR439065 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02485327 ↗ |
| Route | Other | “Route of administration: oral inhalation” NCT02485327 ↗ |